Verrica Pharmaceuticals Inc (VRCA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -18,638 | -8,470 | -35,080 | -25,540 | -12,711 |
| Depreciation Amortization | 397 | 207 | 538 | 272 | 161 |
| Accounts payable and accrued liabilities | -131 | -314 | 497 | 522 | 435 |
| Other Working Capital | -307 | -1,693 | -535 | 557 | 309 |
| Other Operating Activity | 3,158 | 1,930 | 6,998 | 5,305 | 3,520 |
| Operating Cash Flow | $-15,521 | $-8,340 | $-27,582 | $-18,884 | $-8,286 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 50,000 | 47,508 | 69,000 | 54,800 | 35,600 |
| PPE Investments | -305 | -10 | -1,084 | -723 | -684 |
| Purchase Of Investment | -4,477 | -4,485 | -68,914 | -59,086 | -46,216 |
| Investing Cash Flow | $45,218 | $43,013 | $-998 | $-5,009 | $-11,300 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | 4,975 | 4,975 | 4,975 |
| Debt Repayment | -2 | -1 | -5 | -3 | -1 |
| Common Stock Issued | 0 | 0 | 28,676 | 28,677 | 28,632 |
| Other Financing Activity | -17 | -17 | 0 | 0 | 0 |
| Financing Cash Flow | $-19 | $-18 | $33,646 | $33,649 | $33,606 |
| Beginning Cash Position | 15,752 | 15,752 | 10,686 | 10,686 | 10,686 |
| End Cash Position | 45,430 | 50,407 | 15,752 | 20,442 | 24,706 |
| Net Cash Flow | $29,678 | $34,655 | $5,066 | $9,756 | $14,020 |
| Free Cash Flow | |||||
| Operating Cash Flow | -15,521 | -8,340 | -27,582 | -18,884 | -8,286 |
| Capital Expenditure | -305 | -10 | -1,084 | -723 | -684 |
| Free Cash Flow | -15,826 | -8,350 | -28,666 | -19,607 | -8,970 |